ACA vs PFE · P/E 57, rev $2.88B vs P/E 20, rev $62.58B
Arcosa Inc (ACA) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Arcosa Inc (ACA) is a engineering & construction company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported ACA revenue for 2025-12-31 was $2.88B. Net income was $208.4M. Revenue was up 12.2% from 2024-12-31 to 2025-12-31. ACA currently screens at market cap $4.39B and trailing P/E 56.6.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
ACA currently screens at market cap $4.39B and trailing P/E 56.6. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the ACA and PFE stock pages for the full models.
Not investment advice.